Q-Vitalis™

Q-Vitalis™
Product Description

Q-Vitalis™ is a next-generation magnesium raw material engineered with QuanticSphere™ (PQNS) phospholipid nano-delivery technology to overcome the low absorption and gastrointestinal limitations of conventional magnesium salts. The ingredient is designed to deliver magnesium efficiently at the cellular level, supporting energy metabolism, neuromuscular function, and metabolic balance in finished nutraceutical formulations.

Read more Show less

Crassula Pharmaceuticals

  • Country/Region:
    United States
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Academic/Research
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    QuanticSphere™ (PQNS – Phytosome Quantum Nano-Sphere Technology) 

    Minerals • Functional Ingredients • Enhanced Bioavailability Ingredients

    Functional Benefits
    • Enhanced intestinal and intracellular magnesium uptake

    • Controlled release with sustained cellular retention

    • Improved tolerance vs conventional magnesium salts

    • Lower dose requirement with higher functional efficiency
    Performance Highlights
    • ~3.7× higher intracellular absorption vs magnesium ascorbate/sulfate

    • Validated Hep2 cell ICP-MS uptake data

    • Stable intracellular retention with reduced extracellular loss

    • Superior gastrointestinal tolerance

  • Selling Points
    Bone & Joint Health; Cardiovascular Health; Energy & Endurance;
    • PQNS nano-delivery vs conventional magnesium salts

    • Higher cellular uptake, lower dose

    • Improved tolerability and compliance

    • Designed specifically as a B2B magnesium ingredient



  • Model
    Nutraceutical Raw Material / Functional Mineral Ingredient
More specifications Fewer specifications
Sales Markets
Show more Show less

Crassula Pharmaceuticals

  • Country/Region:
    United States
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Academic/Research
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile

More Products from Crassula Pharmaceuticals (2)

  • Q-Curviva™

    Product Q-Curviva™

    Q-Curviva™ is a high-performance curcumin raw material engineered using QuanticSphere™ (PQNS) phospholipid nano-delivery technology to overcome curcumin’s intrinsic limitations of poor solubility, rapid metabolism, and low oral bioavailability. The ingredient is designed for use in finished nutraceutical f...
  • Q-NiFlex™

    Product Q-NiFlex™

    Q-NiFlex™ is a next-generation 16-in-1 multi-target joint restoration nutraceutical engineered to support cartilage regeneration, joint protection, mobility, and long-term inflammation control. Formulated using QuanticSphere™ (PQNS) technology, Q-NiFlex™ overcomes the bioavailability limitations of convent...

Crassula Pharmaceuticals resources (2)

  • Launch of QuanticSphere™ (PQNS) – Advanced Phospholipid Nano-Delivery Platform

    News Launch of QuanticSphere™ (PQNS) – Advanced Phospholipid Nano-Delivery Platform

    Crassula Pharmaceuticals announces the launch of QuanticSphere™ (PQNS), a proprietary phospholipid-based nano-delivery technology designed to improve the bioavailability, stability, and controlled release of nutraceutical and functional ingredients. The platform addresses absorption limitations commonly associated with lipophilic and poorly soluble actives and is available for ingredient and CDMO applications.
    26 Dec 2025
  • Q-NiFlex™ – Multi-Target Joint Support Formulation Powered by QuanticSphere™

    Video Q-NiFlex™ – Multi-Target Joint Support Formulation Powered by QuanticSphere™

    Q-NiFlex™ is a multi-ingredient joint support nutraceutical formulated using QuanticSphere™ (PQNS) phospholipid nano-delivery technology.

    The formulation integrates a broad matrix of structural, anti-inflammatory, antioxidant, and supportive actives designed to address key aspects of joint function, mobility, and long-term musculoskeletal support.

    QuanticSphere™ PQNS technology is applied to enhance the absorption, stability, and controlled release of traditionally low-bioavailability ingredients. This enables improved systemic exposure at lower doses while supporting gastrointestinal tolerance.

    Q-NiFlex™ is developed for nutraceutical and preventive health applications and is manufactured under WHO-GMP and ISO-certified quality systems, with scalability for global markets.
    2025-12-26